Sygnature Discovery

Weight loss is only part of the story. Understanding how treatments affect body composition and muscle function can provide deeper insight into obesity research.

Better decisions drive faster discovery. That's why we integrate AI, automation and experimental science throughout the drug discovery process.

What if you could answer critical discovery questions sooner? Direct-to-Discovery extends Direct-to-Biology, integrating key disciplines earlier into the process.

Some drug discovery partners have pipelines of their own. We don't. Every decision, every resource and every effort is focused on your success.

Exposure, efficacy or formulation? See how combining scientific expertise helps identify what's holding a compound back, and what to do next.

Translational success is rarely determined in the clinic. Discover how biomarker strategies built during discovery can reduce uncertainty much earlier.